Postdoctoral Clinical Researcher

• Oct 2021 - Present

Early stage researcher Foie GRAS project

• Oct 2018 - Aug 2021

Responsible to Investigate how internal and external mediators underlying metabolic dysfunction, including hepatic bioenergetic remodeling and modified gut-liver crosstalk, influence Non-alcoholic fatty liver disease (NAFLD) progression, to ascertain novel biomarkers and therapeutic /lifestyle targets and to develop and implement science in society initiatives addressing NAFLD awareness. Responsible to Investigate how internal and external mediators underlying metabolic dysfunction, including hepatic bioenergetic remodeling and modified gut-liver crosstalk, influence Non-alcoholic fatty liver disease (NAFLD) progression, to ascertain novel biomarkers and therapeutic /lifestyle targets and to develop and implement science in society initiatives addressing NAFLD awareness.

Clinical Researcher

• Apr 2021 - Jun 2021

To address the hypothesis that Adiponectin, Leptin, Resistin, and Chemerin in Non-alcoholic fatty liver disease subjects with or without diabetes where different and reflected a different metabolic phenotype of NAFLD and perform these evaluations using ELISA. To address the hypothesis that Adiponectin, Leptin, Resistin, and Chemerin in Non-alcoholic fatty liver disease subjects with or without diabetes where different and reflected a different metabolic phenotype of NAFLD and perform these evaluations using ELISA.

Assistant Analytical and Automation Scientist

• Sep 2017 - Feb 2018

Was responsible for setting up, optimizing, operating, and maintenance of Robot GWEN and development of new methods to assess foam characteristics of known differentiated home and personal care products. Improving and troubleshooting of existing robotic platforms, as well as designing new robotic solutions. Work with senior scientists to develop, establish, and execute automated High Throughput Screening assays. Compilation of risk assessments, data processing, interpretation, and statistical evaluation of results. Presentation of the data output to the core automation, analytical team, and the director of Materials innovation factory Liverpool Unilever. Interaction with various stakeholders (categories, external suppliers, projects teams, etc.) Show less

Research Associate

• Jul 2016 - Sep 2017

Was responsible to develop a quantitative HPLC protocol for N-acetyl PAHA or PABG isolation so that they can be analysed for acetyl and glucoronate 2H and 13C enrichment by NMR. Was responsible to develop a quantitative HPLC protocol for N-acetyl PAHA or PABG isolation so that they can be analysed for acetyl and glucoronate 2H and 13C enrichment by NMR.

Research Associate

• Nov 2015 - Jul 2017

To screen and characterize the bioactive compounds from Salicornia macrostachya Moric (seaweeds)extracts and to analyze it using HPLC, Raman and FITR spectroscopies. To screen and characterize the bioactive compounds from Salicornia macrostachya Moric (seaweeds)extracts and to analyze it using HPLC, Raman and FITR spectroscopies.

Project work

• Dec 2013 - Jun 2014

Project title and outline: Solid Microneedle Technology for Drug Delivery Applications. Solid micro needles technology for drug delivery applications is a rational basis for designing, coating solution formulations for uniform and thick coatings on microneedles and to identify coating strategies to form composite coatings, deliver liquid formulations, and control the mass deposited on micro needle. Sharp-tipped microneedles, including pocketed microneedles, were fabricated. Rapid delivery of the drug into the artificial skin was studied. Show less